A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab
Clinical trial NCT04537429 · COMPLETED
Trial details
- NCT number
- NCT04537429
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-04
- Primary completion
- 2022-10-20
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.